posted on 2014-01-09, 00:00authored byLinda C. Cummings, Ninad Shah, Santo Maimone, Wajeeh Salah, Vijay Khiani, Amitabh Chak
Background: Prior studies suggest that obstructive sleep apnea may be associated with gastroesophageal reflux disease,
a strong risk factor for Barrett’s esophagus. The goals of this pilot case–control study were to determine whether Barrett’s
esophagus patients have an increased likelihood of obstructive sleep apnea and to determine whether nocturnal
gastroesophageal reflux symptoms affect the relationship between Barrett’s esophagus and obstructive sleep apnea risk.
Methods: Patients with Barrett’s esophagus completed the Berlin Questionnaire, a validated survey instrument identifying
subjects at high risk for obstructive sleep apnea. Two outpatient control groups were recruited: 1) EGD Group, subjects
matched to Barrett’s esophagus cases by age, race, and gender with esophagogastroduodenoscopy negative for Barrett’s
esophagus; and 2) Colonoscopy Group, patients getting colonoscopy. Rates of scoring at high risk for obstructive sleep
apnea were compared. Respondents were also questioned regarding severity of their typical gastroesophageal reflux
symptoms and presence of nocturnal gastroesophageal reflux symptoms.
Results: The study included 287 patients (54 Barrett’s esophagus, 62 EGD, and 171 colonoscopy subjects). Barrett’s
esophagus patients were slightly older than colonoscopy patients and more obese. 56% (n = 30) of Barrett’s esophagus
subjects scored at high risk for obstructive sleep apnea, compared with 42% (n = 26) of EGD subjects (OR 1.73, 95% CI
[0.83, 3.62]) and 37% (n = 64) of colonoscopy patients (OR 2.08, 95% CI [1.12, 3.88]). The association between Barrett’s
esophagus and scoring at high risk for obstructive sleep apnea compared with colonoscopy patients disappeared after
adjusting for age. Barrett’s esophagus patients reported more severe typical heartburn and regurgitation symptoms than
either control group. Among all subjects, patients with nocturnal reflux symptoms were more likely to score at high risk
for obstructive sleep apnea than patients without nocturnal reflux.
Conclusions: In this pilot study, a high proportion of Barrett’s esophagus subjects scored at high risk for obstructive
sleep apnea. Having Barrett’s esophagus was associated with more severe gastroesophageal reflux symptoms, and
nocturnal reflux symptoms were associated with scoring at high risk for obstructive sleep apnea. The need for
obstructive sleep apnea screening in Barrett’s esophagus patients with nocturnal gastroesophageal reflux symptoms
should be further evaluated.
Funding
This study was funded in part by Respironics Sleep and Respiratory Research
Foundation (SPC106642) to AC and support from the Division of
Gastroenterology and Liver Disease, University Hospitals Case Medical Center.
LCC was supported by an NIH Postdoctoral Training Grant in Digestive
Diseases (T32-DK61917), NIH Paul Calabresi Award for Clinical Oncology (K12
CA076917), and Case SPORE in GI Malignancies (P50 CA150964). AC was
supported by a Midcareer Award in Patient Oriented Research
(K24DK002800) from the NIDDK.